Markets:

Overview

News

Currencies

International

Treasuries

Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

7.050 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Wave Life Sciences Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes

June 26, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 24, 2023

Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.

Via Benzinga

WAVE Life Sciences's Return On Capital Employed Overview ↗

May 10, 2023

Via Benzinga

Recap: WAVE Life Sciences Q1 Earnings ↗

May 03, 2023

Via Benzinga

Looking Into WAVE Life Sciences's Return On Capital Employed ↗

March 23, 2023

Via Benzinga

WAVE Life Sciences's Earnings: A Preview ↗

March 21, 2023

Via Benzinga

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023

July 27, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Analyst Creates Bullish Pitch For WAVE Life Sciences, Says It Is 'Leader To Clinic In RNA Editing' ↗

July 05, 2023

Raymond James has initiated coverage on WAVE Life Sciences Ltd (NASDAQ: WVE) with a price target of $9 and

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023 ↗

July 05, 2023

Via Benzinga

Analyst Ratings for WAVE Life Sciences ↗

June 23, 2023

Via Benzinga

Looking Into WAVE Life Sciences's Return On Capital Employed ↗

December 20, 2022

Via Benzinga

Wave Life Sciences Touts Encouraging Data From Duchenne Muscular Dystrophy Study ↗

December 19, 2022

Via Benzinga

Wave Life Sciences' Stock Falls: Investigational Therapy Fails To Show Clinical Benefit In Rare Neurological Diseases ↗

May 23, 2023

Wave Life Sciences Ltd (NASDAQ: WVE) announced topline results from the Phase 1b/2a FOCUS-C9 study evaluating WVE-004 as an investigational treatment for C9orf72-associated amyotrophic lateral...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 23, 2023

Via Benzinga

Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

May 23, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting

May 16, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Estee Lauder, NerdWallet, Sprout Social And Other Big Stocks Moving Lower On Wednesday ↗

May 03, 2023

U.S. stocks mostly traded higher, but the Dow Jones lost around 19 points on Wednesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update

May 03, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023

April 26, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry

April 20, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days

March 29, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 22, 2023

Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.

Via Benzinga

Earnings Scheduled For March 22, 2023 ↗

March 22, 2023

Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earnings at $1.09 per share on revenue of $848.27 million.

Via Benzinga

Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

March 22, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023

March 02, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference

February 09, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

20 Favorite Biotech & Medical Stocks For 2023 ↗

December 28, 2022

The way these stocks are setting up, many of them look great and will be at the forefront this coming year.

Via Talk Markets

Wave Life Sciences Provides Positive Update on Proof-of-Concept Study for WVE-N531 in Duchenne Muscular Dystrophy

December 19, 2022

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 14, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.